Grigorova L V, Rozkin M Ia, Rybin V K, Efimov V S, Makarov N V
Farmakol Toksikol. 1990 Nov-Dec;53(6):31-3.
The comparative study of the antiheparin activity and acute toxicity of the commercial preparation stellin and its homogeneous fractions was carried out. The summary preparation stellin along with a low antiheparin activity possessed a high toxicity explained by the content of ballast proteins of the nonprotamin nature. One of the homogeneous fractions--stellin B had the best antiheparin properties (heparin neutralizing ratio of 8:1 w:w) and a low toxicity due to a high content of arginine residues and a rigid macromolecular structure facilitating the interpolymer interaction with heparin.
对商业制剂司他丁及其均一馏分的抗肝素活性和急性毒性进行了比较研究。总结制剂司他丁除具有低抗肝素活性外,还具有高毒性,这可由非鱼精蛋白性质的杂质蛋白含量来解释。其中一种均一馏分——司他丁B具有最佳的抗肝素特性(肝素中和比为8:1 w:w),且由于精氨酸残基含量高和刚性大分子结构有利于与肝素的聚合物间相互作用,其毒性较低。